Thyrocare Technologies Ltd

₹ 648 1.22%
07 Dec - close price
thyrocare.com BSE: 539871 NSE : THYROCARE
About

Thyrocare Technologies is engaged in the business of healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India.

Key Points

World’s leading Diagnostic center Incorporated in the year 1996, as a single economical thyroid testing center in Mumbai and now has become the world's leading Diagnostic chain which offers a wide range of medical diagnostic tests and management of diseases and disorders. [1]

Website BSE NSE
  • Market Cap ₹ 3,430 Cr.
  • Current Price ₹ 648
  • High / Low ₹ 1,132 / 600
  • Stock P/E 44.3
  • Book Value ₹ 91.4
  • Dividend Yield 2.31 %
  • ROCE 41.1 %
  • ROE 30.8 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 27.9%
  • Company has been maintaining a healthy dividend payout of 65.3%

Cons

  • Stock is trading at 7.09 times its book value
  • Promoters have pledged 100% of their holding.
  • Debtor days have increased from 36.1 to 60.3 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022
108 98 94 54 149 132 139 159 169 110 123 119 125
57 55 64 45 87 83 88 89 82 74 86 85 96
Operating Profit 51 43 29 10 62 49 51 71 87 36 37 34 30
OPM % 47% 43% 31% 17% 42% 37% 36% 44% 52% 33% 30% 28% 24%
3 1 -42 1 5 3 2 3 2 1 2 1 1
Interest 0 0 0 0 0 0 0 1 1 1 1 1 1
Depreciation 5 5 6 4 5 6 6 6 7 7 9 8 8
Profit before tax 48 39 -18 6 62 46 47 67 82 29 29 27 22
Tax % 23% 23% 1% 30% 26% 26% 25% 28% 26% 22% 31% 24% 35%
Net Profit 37 30 -18 4 46 34 35 48 61 23 20 20 14
EPS in Rs 7.09 5.66 -3.42 0.84 8.66 6.48 6.68 9.15 11.45 4.27 3.85 3.80 2.70
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
78 109 134 150 180 235 298 332 370 401 474 562 478
43 60 71 81 109 140 182 193 222 233 304 331 342
Operating Profit 35 49 64 69 71 95 115 139 148 168 171 231 136
OPM % 45% 45% 47% 46% 40% 40% 39% 42% 40% 42% 36% 41% 28%
4 5 18 7 13 6 -16 21 14 -35 12 7 5
Interest 0 0 0 0 0 1 0 0 0 1 1 2 2
Depreciation 1 2 3 6 11 11 12 12 14 20 21 28 32
Profit before tax 38 52 78 69 73 89 87 148 147 112 161 207 107
Tax % 34% 33% 27% 33% 33% 34% 46% 35% 35% 29% 26% 27%
Net Profit 25 35 57 46 49 59 47 96 95 79 120 152 77
EPS in Rs 22.97 32.32 52.04 42.28 9.75 10.94 8.69 17.87 18.04 15.01 22.65 28.74 14.62
Dividend Payout % 0% 0% 0% 0% 157% 91% 115% 56% 111% 33% 110% 52%
Compounded Sales Growth
10 Years: 18%
5 Years: 14%
3 Years: 15%
TTM: -20%
Compounded Profit Growth
10 Years: 16%
5 Years: 19%
3 Years: 17%
TTM: -57%
Stock Price CAGR
10 Years: %
5 Years: -1%
3 Years: 4%
1 Year: -38%
Return on Equity
10 Years: 24%
5 Years: 25%
3 Years: 28%
Last Year: 31%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Sep 2022
11 11 11 11 51 54 54 54 53 53 53 53 53
Reserves 57 92 149 195 229 322 364 400 403 325 393 468 431
25 25 25 25 0 0 0 0 0 9 10 21 19
8 10 11 14 14 39 26 31 32 55 73 55 55
Total Liabilities 101 137 197 246 293 414 444 485 488 442 528 597 558
16 20 75 87 83 93 89 103 108 112 119 149 143
CWIP 0 0 10 6 6 1 2 0 1 4 8 2 4
Investments 24 24 77 119 162 266 299 315 289 239 274 259 213
61 93 34 33 42 55 54 68 89 88 127 186 198
Total Assets 101 137 197 246 293 414 444 485 488 442 528 597 558

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
31 37 46 46 36 67 89 112 97 136 111 106
-24 -18 -88 -52 -21 -19 -40 -48 -3 27 -53 -12
25 0 1 0 -23 -45 -48 -65 -96 -163 -58 -87
Net Cash Flow 32 19 -42 -6 -7 3 1 -1 -3 1 0 6

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 14 11 9 12 9 11 7 10 11 14 34 60
Inventory Days 62 64 54 54 47 54 64 66 54 60 50 54
Days Payable 55 7 2 13 5 8 4 23 19 62 48 30
Cash Conversion Cycle 21 68 61 53 51 57 68 53 46 12 37 84
Working Capital Days 53 91 19 22 52 15 28 11 4 -9 9 49
ROCE % 55% 47% 50% 33% 27% 27% 29% 33% 31% 36% 37% 41%

Shareholding Pattern

Numbers in percentages

Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022
66.01 66.01 66.04 66.11 66.14 66.14 66.14 71.22 71.18 71.18 71.18 71.14
10.76 16.16 17.67 17.87 20.78 20.54 13.19 12.10 12.02 12.68 12.82 10.42
14.83 9.30 10.38 10.86 7.42 7.18 6.38 6.59 6.71 6.88 7.15 9.14
8.39 8.52 5.91 5.16 5.66 6.14 14.29 10.09 10.09 9.26 8.85 9.29

* The XBRL reporting format changed from Sep'2022 onwards. The new format added details about banks and foreign portfolio investors. These were not available earlier.
The sudden increase in FII or DII might be because of these changes.

Please click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls